Document Detail

Peroxisome proliferator-activated receptor gamma agonists potentiate the cytotoxic effect of valproic acid in multiple myeloma cells.
MedLine Citation:
PMID:  19793255     Owner:  NLM     Status:  In-Process    
The main challenge in using chemotherapy to treat multiple myeloma (MM) is drug resistance. In order to evaluate the anti-neoplastic properties of a new drug combination in MM, two clinically available drugs, valproic acid (VPA) a histone deacetylase (HDAC) inhibitor and pioglitazone, a peroxisome proliferator-activated receptor gamma (PPARgamma) agonist, were tested in vitro on MM cell lines and MM patient cells. The sensitivity towards VPA alone was observed on several MM cell lines tested and also on primary myeloma cells and peripheral blood mononuclear cells from healthy donors. Importantly, the addition of a PPARgamma agonist to the VPA treatment increased the cytotoxic effect of VPA in a synergistic/additive manner on the different MM cell lines and MM patient cells. This effect was observed at the physiological range of VPA used to treat epileptic patients. The mechanisms underlying this increase induced a cell cycle arrest and caspase-dependent apoptosis. The potentiation of the effect of VPA by pioglitazone was mediated by higher acetylation levels of histones H3 and H4 compared to levels induced by HDAC inhibitors alone. This association reveals a new promising chemotherapeutic combination to be tested in MM.
Nassera Aouali; Valérie Palissot; Victoria El-Khoury; Etienne Moussay; Bassam Janji; Sandrine Pierson; Nicolaas H C Brons; Laurent Kellner; Manon Bosseler; Kris Van Moer; Guy Berchem
Related Documents :
25081755 - The neuroblastoma and ganglion components of nodular ganglioneuroblastoma are genetical...
23009365 - Primary human hepatocytes vs. hepatic cell line: assessing their suitability for in vit...
23305235 - Glial cell line-derived neurotrophic factor: characterization of mammalian posttranslat...
23763495 - Investigation of parameters influencing incorporation, retention and cellular cytotoxic...
2822825 - Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar ...
10806485 - An encore for ribosome biogenesis in the control of cell proliferation.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-09-29
Journal Detail:
Title:  British journal of haematology     Volume:  147     ISSN:  1365-2141     ISO Abbreviation:  Br. J. Haematol.     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2009-11-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  England    
Other Details:
Languages:  eng     Pagination:  662-71     Citation Subset:  IM    
Laboratoire d'Hémato-Cancérologie Expérimentale, CRP-Santé, Val Fleuri, Luxembourg.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Immune dysregulation and dyserythropoiesis in the myelodysplastic syndromes.
Next Document:  In Process Citation